This case simulation—grounded in patterns observed across hundreds of clinical consultations—is designed to support evidence-informed interpretation of the Hormone Zoomer (Male) Sample Report.
A 46-year-old male presents with a primary goal of improving energy, sleep quality, and overall recovery. Despite maintaining a physically active lifestyle and a clean diet, he reports persistent symptoms suggestive of underlying neuroendocrine imbalance.
His primary concerns include:
He also has a history of trauma/PTSD, which may contribute to ongoing dysregulation of the stress response system.
He is not currently taking any medications and has no surgical history. His only supplement is a standard men’s multivitamin. Family history is unknown.
While his lifestyle appears optimized on the surface, his symptom pattern raises suspicion for subclinical dysfunction in stress physiology, circadian rhythm, and recovery capacity.
Given the patient’s presentation (particularly poor sleep, difficulty relaxing, and trauma history) the provider pursued comprehensive hormone testing with a focus on:
The goal was to evaluate HPA axis function, circadian signaling, and metabolic stress burden, and to determine whether these systems could explain the patient’s symptoms.
Salivary cortisol reflects free, bioavailable cortisol and is the preferred method for assessing dynamic HPA axis signaling.
This patient demonstrates a blunted cortisol awakening response (CAR), characterized by:
This pattern reflects reduced HPA axis responsiveness, commonly seen in individuals with chronic stress exposure or trauma history.
Clinically, a blunted CAR is associated with:
Urinary cortisol reflects total cortisol production and metabolized output over time, offering insight into overall adrenal activity rather than moment-to-moment signaling.
This patient demonstrates a flattened diurnal cortisol curve, with:
This pattern contributes directly to:
Cortisone represents the inactive metabolite of cortisol, and its levels provide insight into cortisol clearance and enzymatic activity (11β-HSD).
Findings include:
This suggests:
Importantly, this is not indicative of pathology (e.g., Cushing’s), but rather reflects chronic stress adaptation and altered hormone metabolism.
DHEA-S, a key marker of adrenal reserve and resilience, is in the lower range.
Additionally, several androgen markers fall in the low-normal to borderline range, suggesting:
Clinically, this may contribute to:
This pattern highlights the relationship between chronic stress and androgen suppression, where prolonged HPA axis activation can downregulate anabolic pathways.
Melatonin production is suboptimal at night, indicating impaired circadian rhythm signaling.
This contributes directly to:
The coexistence of elevated nighttime cortisol + low melatonin creates a cortisol–melatonin mismatch, a key driver of the patient’s symptoms.
Allopregnanolone, a neuroactive metabolite of progesterone, supports GABAergic signaling and promotes relaxation.
Low levels suggest:
This aligns closely with:
Elevated Bisphenol A (BPA), an endocrine-disrupting compound, introduces an additional layer of physiologic stress.
BPA exposure has been associated with:
In this case, BPA may contribute to:
8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative DNA damage, is elevated, indicating increased oxidative stress.
This may reflect:
Elevated oxidative stress can further:
This case illustrates a pattern of chronic stress–driven HPA axis dysregulation, compounded by circadian disruption, endocrine burden, and reduced anabolic reserve.
Key features include:
Together, these findings reflect a state of impaired recovery physiology, where the body is unable to effectively transition between activation and restoration.
This case highlights a common but often overlooked clinical scenario:
Patients may appear healthy based on lifestyle and standard labs, yet still experience significant dysfunction at the level of neuroendocrine regulation.
Key takeaways:
The Hormone Zoomer provides a comprehensive assessment of endocrine function, enabling providers to identify clinically meaningful patterns that are not captured through conventional testing.
In this case, the patient’s symptoms are best explained by chronic stress–driven dysregulation of the HPA axis, circadian rhythm disruption, and environmental burden, underscoring the importance of advanced hormone testing in guiding personalized care.